PharmiWeb.com (press release)Biovest International, Inc. (OTCQB: BVTI), a majority-owned subsidiary of Accentia Biopharmaceuticals, Inc. (OTCQB: ABPI), today announced that an abstract reporting new data from the BiovaxID® Phase II mantle cell lymphoma clinical trial conducted ...
PharmiWeb.com (press release)Biogen Idec (NASDAQ: BIIB) and Elan Corporation, plc (NYSE: ELN) today announced that the New England Journal of Medicine published research from the companies’ global risk management program that updates the risk of TYSABRI® ...
PharmiWeb.com (press release)Medtronic, Inc. (NYSE: MDT) today announced new results from the Medtronic CoreValve ADVANCE Study, which found that women and men benefitted similarly from the Medtronic CoreValve® System. The study, presented at EuroPCR 2012, evaluated patients who ...
PharmiWeb.com (press release)Äù To celebrate the new partnership and support Kimball in his quest to win the 96th Indianapolis 500 Mile Race, Novo Nordisk has commissioned a digital billboard in Times Square featuring its insulin delivery system NovoLog¬Æ FlexPen¬Æ (insulin ...
PharmiWeb.com (press release)PA),a medical technology company commercializing the world's first and only Self-Apposing® Stent to treat Acute Myocardial Infarction (AMI), announced today the definite results on the 1000-patient APPOSITION III clinical study at one month after ...
PharmiWeb.com (press release)Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced the initiation of a Phase 2 study evaluating ZEVALIN® ...
PharmiWeb.com (press release)Furiex Pharmaceuticals, Inc. (NASDAQ: FURX) and Menarini Group today announced that they have entered into a license agreement by which Furiex will license to Menarini rights to commercialize Priligy® in Europe, most of Asia, Africa, Latin America ...
PharmiWeb.com (press release)Cappella Medical Devices Ltd (Cappella), a medical device company developing dynamic solutions for the treatment of coronary bifurcation disease, is pleased to announce new long term follow up clinical data for its innovative Sideguard® coronary ...
PharmiWeb.com (press release)Liquidia Technologies today announced the results of two newly-released studies that illustrate the unique benefits of the company’s proprietary PRINT® (Particle Replication In Non-Wetting Templates) platform in the development of advanced ...
PharmiWeb.com (press release)(India, Delhi– May 16, 2012) – The Bristol-Myers Squibb Foundation today announced the expansion of its Together on Diabetes® initiative to India and China, pledging $15 million over five years to help these developing nations with rapidly ...
